APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics. - Abushakra S; Porsteinsson AP; Sabbagh M; Watson D; Power A; Liang E; MacSweeney E; Boada M; Flint S; McLaine R; Kesslak JP; Hey JA; et al. (Alzheimer's & dementia (New York, N. Y.), 2024)